Presentation
19 April 2017 Laser immunotherapy for metastatic pancreatic cancer (Conference Presentation)
Author Affiliations +
Proceedings Volume 10065, Biophotonics and Immune Responses XII; 1006508 (2017) https://doi.org/10.1117/12.2250212
Event: SPIE BiOS, 2017, San Francisco, California, United States
Abstract
Pancreatic cancer is an extremely malignant disease with high mortality rate. Currently there is no effective therapeutic strategy for highly metastatic pancreatic cancers. Laser immunotherapy (LIT) is a combination therapeutic approach of targeted phototherapy and immunotherapy, which could destroy treated primary tumors with elimination of untreated metastases. LIT affords a remarkable efficacy in suppressing tumor growth in pancreatic tumors in mice, and results in complete tumor regression in many cases. LIT could synergize targeted phototherapy and immunological effects of immunoadjuvant, which represent a promising treatment modality to induce systemic antitumor response through a local intervention, paving the way for the treatment of highly metastatic pancreatic cancers.
Conference Presentation
© (2017) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Feifan Zhou "Laser immunotherapy for metastatic pancreatic cancer (Conference Presentation)", Proc. SPIE 10065, Biophotonics and Immune Responses XII, 1006508 (19 April 2017); https://doi.org/10.1117/12.2250212
Advertisement
Advertisement
KEYWORDS
Pancreatic cancer

Tumors

Phototherapy

Laser therapeutics

Biomedical optics

Current controlled current source

Back to Top